ストックスクリーナーアプリを入手
186.12
0.84%
1.5977
前日終値:
$184.52
開ける：
$184.44
24時間の取引高:
48,418
Relative Volume:
0.22
時価総額：
$3.65B
収益：
$152.42M
当期純損益:
$45.24M
株価収益率:
74.15
EPS:
2.51
ネットキャッシュフロー:
$6.97M
1週間 パフォーマンス:
+0.45%
1か月 パフォーマンス:
+5.04%
6か月 パフォーマンス:
+69.37%
1年 パフォーマンス:
+69.45%
1日の値動き範囲:
$184.44
$188.77
1週間の範囲:
$182.87
$194.44
52週間の値動き範囲:
$93.58
$194.44
Ligand Pharmaceuticals Inc Stock (LGND) Company Profile
名前
Ligand Pharmaceuticals Inc
セクター
電話
858-550-7500
住所
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
LGND を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
186.02 | 3.60B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.24 | 106.97B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
656.45 | 68.62B | 14.25B | 4.58B | 3.56B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.59 | 63.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
819.00 | 50.61B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
192.96 | 35.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | 開始されました | Stifel | Buy |
| 2024-10-03 | 開始されました | Oppenheimer | Outperform |
| 2024-07-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-04-14 | 再開されました | Stephens | Overweight |
| 2021-02-04 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-06 | 開始されました | Barclays | Overweight |
| 2020-03-24 | ダウングレード | Argus | Buy → Hold |
| 2020-03-10 | 開始されました | Guggenheim | Neutral |
| 2020-02-06 | 開始されました | The Benchmark Company | Buy |
| 2019-09-19 | アップグレード | Barclays | Equal Weight → Overweight |
| 2019-06-11 | 開始されました | Barclays | Equal Weight |
| 2019-05-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-03-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-10-29 | アップグレード | ROTH Capital | Neutral → Buy |
| 2018-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-11 | 繰り返されました | Argus | Buy |
| 2018-08-17 | 開始されました | Goldman | Neutral |
| 2018-08-08 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2018-06-21 | 開始されました | Argus | Buy |
| 2017-12-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-09-05 | 再開されました | H.C. Wainwright | Buy |
| 2016-10-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-05 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2016-03-11 | 開始されました | Sidoti | Buy |
| 2016-03-03 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Ligand Pharmaceuticals Inc (LGND) 最新ニュース
How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leadersGold Moves & Free Safe Capital Growth Stock Tips - newser.com
Intraday pattern recognizer results for Ligand Pharmaceuticals IncorporatedWeekly Loss Report & Precise Swing Trade Entry Alerts - newser.com
Ligand Pharmaceuticals (LGND) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Will Ligand Pharmaceuticals Incorporated outperform the marketJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com
Will Ligand Pharmaceuticals Incorporated (LGDN) stock announce a stock splitWeekly Profit Report & Community Verified Trade Signals - newser.com
Short interest data insights for Ligand Pharmaceuticals IncorporatedMarket Performance Report & Growth Focused Investment Plans - newser.com
What institutional flow reveals about Ligand Pharmaceuticals IncorporatedChart Signals & High Conviction Buy Zone Picks - newser.com
Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical toolsJuly 2025 Intraday Action & Growth Oriented Trade Recommendations - newser.com
Is Ligand Pharmaceuticals Incorporated forming a reversal patternMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Ligand Pharmaceuticals IncorporatedEquity Right (LGNZZ) Price Target Decreased by 44.49% to 0.08 - Nasdaq
Ligand Pharmaceuticals Reaches Analyst Target Price - Nasdaq
Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correctionStock Surge & Free High Accuracy Swing Entry Alerts - newser.com
What catalysts could drive Ligand Pharmaceuticals Incorporated stock higherPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Can Ligand Pharmaceuticals Incorporated stock sustain market leadership2025 Market Overview & Weekly High Return Opportunities - newser.com
What analyst consensus says on Ligand Pharmaceuticals Incorporated stockWeekly Risk Summary & Free Daily Entry Point Trade Alerts - newser.com
Can technical indicators confirm Ligand Pharmaceuticals Incorporated’s reversalQuarterly Market Review & Community Consensus Trade Signals - newser.com
Why Ligand Pharmaceuticals Incorporated stock is a value investor pickJuly 2025 Chart Watch & Real-Time Stock Entry Alerts - Fundação Cultural do Pará
How to use Fibonacci retracement on Ligand Pharmaceuticals IncorporatedQuarterly Profit Review & Verified Momentum Watchlists - newser.com
Technical signs of recovery in Ligand Pharmaceuticals IncorporatedPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryStop Loss & Intraday High Probability Setup Alerts - newser.com
Does Ligand Pharmaceuticals Incorporated show high probability of reboundJuly 2025 Review & Weekly High Potential Alerts - newser.com
Published on: 2025-10-28 01:03:19 - newser.com
Ligand Pharmaceuticals Incorporated stock daily chart insightsWeekly Profit Report & Community Driven Trade Alerts - newser.com
Price action breakdown for Ligand Pharmaceuticals IncorporatedJuly 2025 Summary & Daily Stock Trend Reports - newser.com
Chart overlay techniques for tracking Ligand Pharmaceuticals IncorporatedWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Ligand Pharmaceuticals Inc (LGND) 財務データ
収益
当期純利益
現金流量
EPS
0.89%
0.62%
大文字化:
|
ボリューム (24 時間):